Providing diverse exposure to innovative tech companies, ARK Innovation ETF is ideal for long-term growth investors.

Cathie Wood is the CEO and chief investment officer at ARK Investment Management. One feature that differentiates Wood from ...

EST Cathie Wood’s ARK Investment bought 344K shares of PacBio (PACB) todayMaximize Your Portfolio with Data Driven Insights:Leverage the ...

EST Cathie Wood’s ARK Investment bought 268K shares of Twist Bioscience (TWST) todayMaximize Your Portfolio with Data Driven ...

Star portfolio manager Cathie Wood’s Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb. 4 ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

In this article, we will take a look at 15 stocks in Cathie Wood’s stock portfolio. Cathie Wood is one of Wall Street’s most ...

Explore Cathie Wood's latest investment insights on the convergence of artificial intelligence in shaping the future, as ...

Ark Invest purchased shares of CRISPR Therapeutics AG for both its ARK Genomic Revolution ETF ARKG and Ark Innovation ETF ARKK. The ARKG ETF bought 43,467 shares, while the ARKK ETF acquired ...

Ohio Police & Fire Pension Fund, Columbus, terminated Western Asset Management Co. from a $180 million short-term cash portfolio. The $18.9 billion pension fund’s board approved the termination ...

Exciting prospects don’t necessarily make a company a good investment. Weight-loss drugs are trending, meaning growth potential may already be accounted for in these company’s share prices.